Finasteride and dutasteride are discussed for hair loss, with concerns about their effects on neurosteroids and potential side effects like depression. Alternatives like topical estrogen and lifestyle changes are considered, with varying opinions on mental health and hair regrowth.
The conversation discusses how different factors can stimulate type1 and type 2 isoforms of 5-alphareductase, which are enzymes linked to hair loss. Specific treatments mentioned include oral Dutasteride and topical Finasteride.
GHK-Cu is a potent inhibitor of the type15-alphareductase enzyme in hair follicles, which may reduce hair loss without the side effects associated with type 2 5-alphareductase inhibitors. The user previously experienced side effects with 5-alphareductase inhibitors and is considering GHK-Cu as an alternative.
Beta-sitosterol may inhibit 5-alphareductasetype 2 enzyme, potentially reducing DHT levels and promoting hair growth, similar to finasteride but possibly with fewer side effects. Its effectiveness and side effects compared to other treatments like saw palmetto and finasteride remain uncertain due to limited research.
Epristeride is a selective 5 alphareductasetype 2 inhibitor that may reduce scalp DHT similarly to finasteride, with potentially fewer side effects. It is suggested that combining epristeride with finasteride or dutasteride could enhance hair loss treatment effectiveness.